July 10th | Equity Mates Live in Melbourne! | Limited Tickets on Sale Now

Argenica Therapeutics (ASX: AGN)

AGN Profile by TradingView
AGN Stock Price Today by TradingView

Latest

  • Argenica Therapeutics: Protecting brains of stroke patients

    Argenica Therapeutics: Protecting brains of stroke patients

    During a stroke, blood vessels are blocked and blood carrying essential oxygen cannot make it to brain cells. This lack of oxygen kills 1.9 million brain cells every minute.

    1 June

    Sponsored by Argenica Therapeutics

  • Uncovered: Protecting brains of stroke patients - Argenica Therapeutics
    General

    Uncovered: Protecting brains of stroke patients - Argenica Therapeutics

    Uncovered is our series where we take a closer look at some of the Aussie companies that get less analyst coverage and media attention. And today’s episode is a cracker.

    31 May

  • Uncovered: Argenica Therapeutics (ASX: AGN)
    General

    Uncovered: Argenica Therapeutics (ASX: AGN)

    Argenica Therapeutics was created to commercialise ARG-007 research. In June 2021, it was listed on the ASX (ticker: AGN) to access the necessary capital to develop and commercialise the drug.

    10th May, 2024

close

Get the latest

Receive regular updates from our podcast teams, straight to your inbox.

The Equity Mates email keeps you informed and entertained with what's going on in business and markets.
The world of cryptocurrencies is a fascinating part of the investing universe these days. For those investing in crypto or interested in learning more about this corner of the market, we’re featuring some of the most interesting content we’ve come across in this weekly email.